Rockwell Medical (RMTI) announced that the company has partnered with HydroCare, a provider of state-of-the-art dialysis water treatment systems to healthcare facilities globally, to purchase and install the company’s dry acid concentrate mix system in dialysis water rooms. Rockwell anticipates that with these new mixer installations through HydroCare, the company will also generate new sales related to its dry acid hemodialysis concentrates. Rockwell Medical’s DAMX45 dry acid concentrate mix system is 510(k) approved to be used exclusively with the company’s CitraPure and Dri-Sate dry acid concentrate powders.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RMTI: